RAPID MICRO BIOSYSTEMS, INC. Quarterly Debt-to-equity in % from Q1 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Rapid Micro Biosystems, Inc. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q3 2024.
Rapid Micro Biosystems, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 22.6 %, a 45.3% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	22.6	+7.06	+45.3%	Sep 30, 2024
Q2 2024	20.6	+6.23	+43.2%	Jun 30, 2024
Q1 2024	18.5	+5.28	+39.9%	Mar 31, 2024
Q4 2023	16.7	+4.18	+33.3%	Dec 31, 2023
Q3 2023	15.6	+4.71	+43.3%	Sep 30, 2023
Q2 2023	14.4	+4.61	+47.1%	Jun 30, 2023
Q1 2023	13.2	-11	-45.4%	Mar 31, 2023
Q4 2022	12.6			Dec 31, 2022
Q3 2022	10.9			Sep 30, 2022
Q2 2022	9.8			Jun 30, 2022
Q1 2022	24.2			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.